ProShare Advisors »

BioCryst Pharmaceuticals shares owned by ProShare Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by ProShare Advisors from 13F filings

Historical chart of ProShare Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by ProShare Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $41k 35k 1.19
2012-09-30 $64k 15k 4.25

More positions owned by ProShare Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Linde SHS (LIN)
Pepsi (PEP)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Automatic Data Processing (ADP)
Netflix (NFLX)

View all positions for ProShare Advisors

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
venBio Select Advisor
Baker Bros. Advisors
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Alkeon Capital Management
RP Management
Rock Springs Capital Management
Jennifer Ranahan
Braidwell
Fisher Investments
Nuveen Asset Management

View all funds holding BioCryst Pharmaceuticals